BioTechGrid

Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal

July 21, 2026

For years, as Big Pharma poured billions into ADCs, Novartis CEO Vas Narasimhan notably stayed on the sidelines. Asked by…

Genetics

Revvity Creates Program to Equip Young Biotechs with Scalable Informatics Capabilities Sooner than Later

July 21, 2026

Credit: Artemis Diana/Getty Images Revvity reports that its Signals Software business is launching Signals for Startups, a new program designed to…

Biotechnology

Jupiter enters psychedelics space with $100M deal for PharmAla’s MDMA drug

July 21, 2026

Jupiter Neurosciences will pay $3.3 million upfront to Canada's PharmAla Biotech for U.S. rights to an MDMA drug to treat…

Biotechnology

Agios says adios to sickle cell program over lackluster phase 2 data

July 21, 2026

A phase 2 study of Agios Pharmaceuticals’ next-generation pyruvate kinase activator has failed to support continued development in sickle cell…

Biotechnology

Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality ‘unchanged’

July 21, 2026

Novartis has dropped a phase 2-stage radioligand therapy after the candidate disappointed in the clinic.

Biotechnology

Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets

July 21, 2026

Lupin has spun out two clinical-phase cancer drug candidates to create Kaveri Therapeutics, a U.S.-based startup that plans to raise…

Medical Technology

Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role

July 21, 2026

Dan Malarek is leaving his role as chief executive of Roche’s sequencing subsidiary Foundation Medicine as he takes up the…

Genetics

Early Genomic Indicators of Praziquantel Resistance in Schistosoma mansoni

July 21, 2026

Credit: defun / iStock / Getty Images Plus The warning signs are subtle—genetic variants scattered across a vast parasite genome—but…

Genetics

Flu Virus Interaction with Host Cell Machinery Mapped Inside Infected Cells

July 20, 2026

Researchers at EMBL Hamburg and collaborators at the Leibniz Research Institute for Molecular Pharmacology (FMP) have mapped in unprecedented detail…

Genetics

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of Tauopathy

July 20, 2026

Credit: Juan Gaertner/Science Photo Library/Getty Images Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In…

Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal

Revvity Creates Program to Equip Young Biotechs with Scalable Informatics Capabilities Sooner than Later

Jupiter enters psychedelics space with $100M deal for PharmAla’s MDMA drug

Agios says adios to sickle cell program over lackluster phase 2 data

Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality ‘unchanged’

Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal

Revvity Creates Program to Equip Young Biotechs with Scalable Informatics Capabilities Sooner than Later

Jupiter enters psychedelics space with $100M deal for PharmAla’s MDMA drug

Agios says adios to sickle cell program over lackluster phase 2 data

Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality ‘unchanged’

Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets

Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role

Early Genomic Indicators of Praziquantel Resistance in Schistosoma mansoni

Flu Virus Interaction with Host Cell Machinery Mapped Inside Infected Cells

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of Tauopathy

Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role

Tempus buys out cancer genomics partner Personalis in $1.5 billion deal

Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businesses

Abbott Q2 led by strong device, diagnostic sales as it boosts profit forecast